Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

NCT06890429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Synctial Virus Infections

Interventions

BIOLOGICAL: RSV/Flu-01E
OTHER: Placebo

Sponsor

Research Institute of Influenza, Russia

Collaborators

[object Object]
[object Object]